243 related articles for article (PubMed ID: 12354780)
1. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains.
Modregger J; DiProspero NA; Charles V; Tagle DA; Plomann M
Hum Mol Genet; 2002 Oct; 11(21):2547-58. PubMed ID: 12354780
[TBL] [Abstract][Full Text] [Related]
2. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements.
DiProspero NA; Chen EY; Charles V; Plomann M; Kordower JH; Tagle DA
J Neurocytol; 2004 Sep; 33(5):517-33. PubMed ID: 15906159
[TBL] [Abstract][Full Text] [Related]
3. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
[TBL] [Abstract][Full Text] [Related]
4. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.
Sayer JA; Manczak M; Akileswaran L; Reddy PH; Coghlan VM
Neuromolecular Med; 2005; 7(4):297-310. PubMed ID: 16391387
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
[TBL] [Abstract][Full Text] [Related]
7. Huntingtin contains a highly conserved nuclear export signal.
Xia J; Lee DH; Taylor J; Vandelft M; Truant R
Hum Mol Genet; 2003 Jun; 12(12):1393-403. PubMed ID: 12783847
[TBL] [Abstract][Full Text] [Related]
8. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
Jana NR; Tanaka M; Wang Gh; Nukina N
Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
[TBL] [Abstract][Full Text] [Related]
10. Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis.
Passani LA; Bedford MT; Faber PW; McGinnis KM; Sharp AH; Gusella JF; Vonsattel JP; MacDonald ME
Hum Mol Genet; 2000 Sep; 9(14):2175-82. PubMed ID: 10958656
[TBL] [Abstract][Full Text] [Related]
11. Huntingtin interacts with a family of WW domain proteins.
Faber PW; Barnes GT; Srinidhi J; Chen J; Gusella JF; MacDonald ME
Hum Mol Genet; 1998 Sep; 7(9):1463-74. PubMed ID: 9700202
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of Huntington's disease.
Walling HW; Baldassare JJ; Westfall TC
J Neurosci Res; 1998 Nov; 54(3):301-8. PubMed ID: 9819135
[TBL] [Abstract][Full Text] [Related]
13. Synaptic dysfunction in Huntington's disease: a new perspective.
Smith R; Brundin P; Li JY
Cell Mol Life Sci; 2005 Sep; 62(17):1901-12. PubMed ID: 15968465
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease: a synaptopathy?
Li JY; Plomann M; Brundin P
Trends Mol Med; 2003 Oct; 9(10):414-20. PubMed ID: 14557053
[TBL] [Abstract][Full Text] [Related]
15. A human HAP1 homologue. Cloning, expression, and interaction with huntingtin.
Li SH; Hosseini SH; Gutekunst CA; Hersch SM; Ferrante RJ; Li XJ
J Biol Chem; 1998 Jul; 273(30):19220-7. PubMed ID: 9668110
[TBL] [Abstract][Full Text] [Related]
16. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
Truant R; Atwal RS; Burtnik A
Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
[TBL] [Abstract][Full Text] [Related]
17. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
18. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
19. SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates.
Sittler A; Wälter S; Wedemeyer N; Hasenbank R; Scherzinger E; Eickhoff H; Bates GP; Lehrach H; Wanker EE
Mol Cell; 1998 Oct; 2(4):427-36. PubMed ID: 9809064
[TBL] [Abstract][Full Text] [Related]
20. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease.
Lecerf JM; Shirley TL; Zhu Q; Kazantsev A; Amersdorfer P; Housman DE; Messer A; Huston JS
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4764-9. PubMed ID: 11296304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
